Categories
Politics

After Backing Army Pressure in Previous, U.S.A.I.D. Nominee Focuses on Deploying Gentle Energy

WASHINGTON – Samantha Power becomes more emotional towards the end of the 2014 documentary, Watchers of the Sky, which traces the origins of the legal definition of genocide. At the time, Ms. Power was President Barack Obama’s Ambassador to the United Nations and, she said, had “great insight into much of the pains” in the world.

To prevent mass atrocities abroad, one had to “consider what we can do about it in order to exhaust the tools at your disposal,” Ms. Power said in the film. “And I always think of the privilege of being able to try – just to try.”

Little doubt about Ms. Power’s zeal – given her career as a war correspondent, human rights activist, academic expert, and foreign affairs advisor – even if it meant advocating military violence to stop widespread murders.

Now, as President Biden’s candidate to lead the US Agency for International Development, she is preparing to re-enter government as administrator of soft power and oppose the use of weapons as a deterrent and punishment against the urged her in the past.

A Senate committee is expected to vote on her nomination as head of one of the world’s largest distributors of humanitarian aid on Thursday.

If confirmed, Mr Biden will also put her on the National Security Council, where during the Obama administration she pushed for military inventions to protect civilians from government-sponsored attacks in Libya in 2011 and Syria in 2013 which declined 2003 invasion of Iraq.)

The fact that she will sit at the table again on the council – and will almost certainly again debate whether American forces should be drawn into ongoing conflict – has worried some officials, analysts and think-tank experts, the military reluctance of the Biden administration demand. Mr Biden seems to be leaning like this: He has embraced economic sanctions as an instrument of hard power and is expected to announce a full withdrawal of American troops from Afghanistan by September 11 to end the longest war in the United States.

“When you are talking about humanity, famine and war, natural causes aside, war is the leading cause of famine around the world,” Kentucky Republican Senator Rand Paul told Ms. Power last month at her Senate confirmation hearing. “Are you ready to admit that the Libyan and Syrian interventions you advocated were a mistake?”

Mrs. Power didn’t. “When these situations arise, it’s almost about less evils – that the decisions are very challenging,” she said.

The US aid agency naturally has a long-term view of the world compared to the immediacy of military action. In addition to the humanitarian aid amounting to around 6 billion US dollars, which it is making available this year for disaster-stricken countries, the agency is trying to prevent conflict at its roots, largely strengthen the economy, counteract state corruption and democracy and promote human rights.

This mission is central to Mr Biden’s foreign policy and may nowhere prove more important than in his global competition with China.

Last month, Foreign Minister Antony J. Blinken reassured allies that they would not return to a “us-or-you” decision with China as the two superpowers vie for economic, diplomatic and military advantage.

Representative Tom Malinowski, Democrat of New Jersey and former Deputy Secretary of State for Democracy and Human Rights of Obama, described in his loan and development projects the “perception that China exports corruption”.

For example, a February study by the International Republican Institute, a private not-for-profit group that receives government funding and promotes democracy, concluded that Panama’s decision in 2017 to sever diplomatic relations with Taiwan “appeared to be due to disbursements” from China was driven. It was also noted that Nepal regularly revoked the legal status of Tibetan refugees after becoming economically dependent on Beijing.

The American aid organization alone cannot keep up with the resources that China has deployed in developing countries. But Mr. Malinowski said his support for journalists, legal advisors and legitimate opposition groups could “expose and combat” caustic foreign leaders who had benefited from Beijing’s financial aid and playbook to stay in power.

“There is a problem that has come to the fore in this government and that it is very focused on, which is fighting corruption,” Malinowski said of Ms. Power. “And USAID may play a very important role there.”

At her confirmation hearing in March, Ms. Power told the senators that she had been moved to pursue a career in foreign affairs following the 1989 massacre of Tiananmen protesters in Beijing. She described China’s “coercive and predatory approach that is so transactional” in dealing with developing countries that ultimately become dependent on Beijing through what she called “debt-trap diplomacy”.

“I think it’s not going so well, and that opens up the United States,” Ms. Power told Indiana Republican Senator Todd Young.

The mostly harmless nudge of Democrats and Republicans during the hearing showed how fighting China has become a rare, if reliable, non-partisan issue in Congress. “I think it is absolutely essential that our development funds are used to advance our geostrategic priorities,” said Young.

The aid agency and the State Department have budgeted around $ 2 billion for programs to promote democracy, human rights and open governance abroad in fiscal 2021 – a third as much as funding humanitarian aid.

It’s an area that Ms. Power is expected to expand into. The Biden government’s first budget released on Friday alleged it was committing an unspecified but “substantial increase in resources” to advance human rights and democracy while thwarting corruption and authoritarianism.

The spending plan will also support another of Ms. Power’s priorities: fighting corruption, violence and poverty in Central America to curb the influx of thousands of migrants who travel to the southwestern border each year. The Biden government is betting on a $ 4 billion strategy through 2025 – including an initial tranche of $ 861 million proposed this year – to help stabilize the region.

In El Salvador, for example, killings fell 61 percent after a USAID attempt to reduce violence from 2015 to 2017, Ms. Power told senators, and the agency’s programs in Honduras have produced similar results. In addition to assisting local prosecutors, the programs brought together government officials, businesses, and church and community leaders to distract young people from gangs through professional training, tutoring, and artistic activities.

She met with some skepticism.

Ohio Republican Senator Rob Portman noted that the number of Central American children on the border has increased steadily since January, despite the fact that the United States has spent $ 3.6 billion on similar efforts over the past five years.

“The results are not impressive,” said Portman. “It’s primarily an economic problem” and “people will still try to get to the US.”

Explaining foreign policy decisions to the American people and making them relevant to their lives is a driving theme for the State Department under Mr. Biden. Ms. Power can draw on her own experience as an immigrant from Ireland and as a storyteller to help alleviate the border crisis by attacking its root causes.

“That’s part of the job – you have to be a salesperson, you have to go out and tell people, ‘So we need more resources to do this job, and this is where USAID can be an incredibly important partner,” said John Prendergast, a longtime veteran Human rights and anti-corruption activist and close friend of Ms. Power.

“There is so much that can be done between bombing and nothing,” said Prendergast, paraphrasing Luis Moreno Ocampo, the former prosecutor of the International Criminal Court featured in the same genocide documentary as Ms. Power. “And all of Samantha’s work and life was between those two extremes.”

Gayle Smith, who ran the aid agency for Mr Obama and is now the State Department’s coronavirus vaccine envoy, put it more clearly.

“It’s not that USAID is going to break into anyone,” she said.

Categories
Business

Pausing use of J&J Covid vaccine is not going to have an effect on timeline of getting U.S. vaccinated, says physician

America’s temporary hiatus from using Johnson & Johnson’s single-dose vaccine Covid-19 will not affect President Joe Biden’s goal of bringing the nation to a semblance of normalcy by Independence Day, said the dean of Brown University’s School of Public Health on Tuesday.

“I think this is going to be a blip on the calendar when it comes to getting Americans vaccinated,” said Dr. Ashish Jha. “I don’t think it will affect the timeline at all.”

Federal health officials advised on Tuesday that the US should temporarily stop using J & J’s single-dose vaccine after six of the roughly 6.9 million people who received the shot reported severe blood clots. The blood clots occurred in women between the ages of 18 and 48 years. One woman died and another is in critical condition. They all developed symptoms 6 to 13 days after the shot, according to the Centers for Disease Control and Prevention and the Food and Drug Administration.

Jha told CNBC’s “The News with Shepard Smith” that the precautionary measures are evidence that “the system is working” and that the government’s swift action could counter the hesitation of the vaccine.

“I hope that it actually builds trust in people, that we don’t take adverse events lightly and investigate them, and that we really make sure that these vaccines are very, very safe.”

Anthony Fauci, director of the National Institute for Allergies and Infectious Diseases, reiterated that the break is “out of caution” and will give health officials time to investigate.

“You want to make sure that security is the important issue here,” Fauci said during a press conference at the White House on Tuesday. “We are fully aware that this is a very rare occurrence. We want this to work as soon as possible.”

Jha told host Shepard Smith that he “expects the break to be days, not much longer,” reiterating Fauci’s claim about the rarity of blood clots.

“The key point here is that this is an incredibly rare, adverse event,” said Jha. “It won’t affect very many people and I think, out of caution, we’ll just pause to see what else we can find out about it.”

Categories
Entertainment

Melissa Villaseñor Impersonates Gwen Stefani on Ellen Present

Melissa Villaseñor’s talent for collecting celebrity impressions is unmatched. During a virtual appearance on The Ellen DeGeneres Show on Tuesday the comedian and Saturday night live The performer showed her uncanny ability to mimic the voices of various stars and seamlessly rattled off six impressions in less than two minutes without breaking a sweat.

She started the game by impersonating actress Wanda Sykes, who rode a roller coaster before turning into a hippo-obsessed Owen Wilson and an angry Lily Tomlin who ordered a pizza on a safari. The real gem came about halfway when Villaseñor revived her flawless Gwen Stefani imitation from the archives when she faked the singer “Hollaback Girl” calling a cab. If you close your eyes before hitting play in the video above, you will no doubt think that DeGeneres interviewed Stefani himself – Villaseñor is so good.

Categories
World News

Inventory futures are flat forward of earnings season kickoff

US stock futures were unchanged in overnight trading on Tuesday before the first corporate profits were made.

Dow futures only fell 10 points. S&P 500 futures rose 0.03% and Nasdaq 100 futures fell 0.02%.

On Tuesday, the S&P 500 rose 0.4% to close at a record high. Stocks shook off calls by the Food and Drug Administration to halt Johnson & Johnson’s Covid-19 vaccine delivery after six people in the U.S. developed a rare blood clot disorder. Moderna stock rose more than 7% on the news.

After Tuesday’s bell, Pfizer CEO Albert Bourla said the drug maker could deliver 10% more vaccine doses to the US than previously expected by the end of May. Also, Moderna said his Covid-19 vaccine was more than 90% effective against the virus six months after a person was shot twice.

The tech-heavy Nasdaq Composite gained more than 1% on Tuesday, with Amazon, Apple, Alphabet, Netflix, Microsoft and Tesla all closing higher.

The Dow Jones Industrial Average lost 68 points after losing more than 150 points at the start of the session.

The Department of Labor’s consumer price index fell a little hotter than expected on Tuesday. The CPI rose by 0.6% on the previous month, but by 2.6% on the same period of the previous year. Economists surveyed by Dow Jones forecast an increase in the overall index of 0.5% compared to the previous month and 2.5% compared to the previous year.

Investors prepare for the first wave of corporate earnings on Wednesday when JPMorgan, Goldman Sachs and Wells Fargo report before the bell. Bank stocks have so far risen sharply this year, with the KBW Bank Index clearly outperforming the S&P 500.

Analysts expect investment banking results to be strong, but credit growth to slow. In addition, the release of credit reserves could lead to high profit figures.

Market participants will also pay attention to Coinbase’s direct listing on Wednesday. Crypto investors are hailing the company’s public debut as a major milestone for the industry after years of skepticism from Wall Street and regulators. Bitcoin price rose to a new record high of more than $ 63,500 on Tuesday.

Federal Reserve Chairman Jerome Powell will speak at the Economic Club of Washington on Wednesday at 12:00 noon on the economic recovery from the pandemic.

Did you like this article?
For exclusive stock selection, investment ideas and CNBC Global Livestream
Sign up for CNBC Pro
Start your free trial now

Categories
Health

J&J Vaccine and Blood Clots: A Danger, if It Exists, Is Tiny

On Tuesday morning, U.S. health officials recommended a break in using Johnson & Johnson’s Covid-19 vaccine while examining six reports of blood clots in women ages 18 to 48. One has died, another is in critical condition in the hospital.

As of Monday, 6.8 million people in the United States had received the vaccine with no other serious side effects reported.

Experts are yet to determine to what extent the vaccine may be responsible for the clots. However, the investigation follows action by European regulators who concluded that a vaccine made by AstraZeneca may also be the cause of a similar, extremely rare, coagulation disorder.

US and European public health experts have emphasized that for most people, the benefits of Covid vaccines far outweigh the risks.

Several countries in Europe last week restricted the use of the AstraZeneca-Oxford vaccine to older adults due to the rare occurrence of a blood disorder in younger people. The AstraZeneca vaccine was not approved in the United States.

Fewer than one in a million J&J vaccinations are currently being studied. If there is indeed a risk of blood clots from the vaccine – which has yet to be determined – the risk is extremely small. The risk of contracting Covid-19 in the United States is much higher.

The FDA recommends people who have received the Johnson & Johnson vaccine within the past three weeks to see their doctor if they have severe headache, abdominal pain, leg pain, or difficulty breathing. Doctors who see people with these symptoms, especially if the patients are young women, should ask if they have recently had a Covid shot, said Dr. Anthony Fauci, senior scientific advisor to the Biden administration, at a press conference Tuesday.

People shouldn’t worry about mild headaches and flu-like symptoms for the first few days after vaccination. These are common, harmless side effects caused by the immune system’s defense against the coronavirus.

For people who got the vaccine a month or two ago, the blood clot problem means “nothing,” said Dr. Fauci. The six cases occurred within a “fairly narrow window” of six to 13 days after people got the shot, he said.

During clinical trials and after the widespread use of vaccines, experts track all of the medical problems that arise in people who receive them. If an unusually large number of cases arise, regulators may decide to stop a study or stop using a vaccine for further investigation.

Breaks are frequent, and tests usually show that the medical problems were incidental. If the investigation reveals that a vaccine poses a risk, regulators can write new guidance on who should or should not receive it. The break also gives them time to advise doctors on how to recognize and treat the disease.

If so, the Food and Drug Administration and Centers for Disease Control and Prevention recommend a break States have already followed the advice of the agencies. Companies that are temporarily discontinuing use of the vaccine include CVS Health and Walgreens.

In a press conference Tuesday, federal officials said the government review would likely only take a few days. A CDC panel is expected to discuss the issue at a meeting on Wednesday.

Six women in the United States who received the Johnson & Johnson vaccine developed a rare blood clot disorder within about two weeks of being vaccinated. In people with this condition called cerebral venous sinus thrombosis, clots form in veins that drain blood from the brain. The results are “stroke-like,” said Dr. Anne Schuchat from the CDC.

Researchers studying a very similar disorder in AstraZeneca recipients in Europe say it appears to be caused by an intense immune system response to the vaccine, which makes antibodies that activate platelets, a blood component that helps to form normal blood clots in the Contributes to wound repair. In addition to clots, abnormal bleeding occurs. European researchers have named the disorder identified there as “vaccine-induced immune thrombotic thrombocytopenia”.

Dr. FDA’s Peter Marks said it was the unusual combination of clotting and bleeding that set a red flag for regulators as a possible safety signal.

So far, researchers have failed to find a way to predict who will develop the disorder and have not identified an underlying condition that could indicate a susceptibility.

Updated

April 13, 2021, 5:17 p.m. ET

Dr. Fauci said if scientists could identify a common core trait among the women who developed the blood clots, it could help identify who is at risk and allow regulators to pinpoint categories of people who are not receiving the J&J vaccine should.

A blood clot is a thickened, gelatinous clot of blood that can block blood flow. Clots form in response to injury and can also be caused by many diseases, including cancer and genetic disorders, certain medications, and prolonged sitting or bed rest. Covid itself can cause serious coagulation problems. Clots that form in the legs sometimes break off and travel to the lungs or, rarely, to the brain, where they can be fatal.

In the United States, 300,000 to 600,000 people each year develop blood clots in their lungs, leg veins, or other parts of the body, according to the CDC

Based on this data, approximately 1,000 to 2,000 blood clots occur daily in the US population. With millions of people being vaccinated every day now, some of these clots appear in those who just happened to receive the shots, regardless of the vaccine.

In the UK, about 1 in 1,000 people are affected by a blood clot in a vein each year, according to regulators.

However, the worrying coagulation disorder among vaccine recipients is much rarer and different from typical blood clots. In addition to clotting in the brain – cerebral venous sinus thrombosis for short, or CVST for short – all patients had remarkably low levels of platelets, which made them prone to abnormal bleeding.

On Tuesday, Johnson & Johnson announced that the company was aware of an extremely rare condition involving people with blood clots combined with low platelets in a small number of people who received the vaccine. “In addition, we have examined these cases with the European health authorities,” said the company in its statement. “We made the decision to proactively delay the launch of our vaccine in Europe.”

At the press conference on Tuesday, Dr. Marks from the FDA said the cases are “very, very similar.”

What You Need To Know About The Johnson & Johnson Vaccine Break In The United States

Both Johnson & Johnson and AstraZeneca use adenoviruses to transport DNA into human cells and begin the process of creating immunity to the coronavirus. It is not yet known if this technology is causing the problem.

German researchers have speculated that DNA from the vaccine could trigger the immune response in some people. However, the condition is so rare that researchers say patients likely also have an individual biological trait – which is still unknown – that predisposes them to the immune overreaction.

Last month, European regulators began investigating similar cases of cerebral vein thrombosis related to low platelets. They concluded that the disorder was a very rare side effect of the AstraZeneca vaccine. It’s too early to know if Johnson & Johnson’s vaccine is responsible for the same type of rare blood clot.

European regulators had recommended that recipients of the vaccine seek medical help for a number of possible symptoms, including leg swelling, persistent abdominal pain, severe and persistent headache or blurred vision, and tiny spots of blood under the skin outside of the area where the Injection was given was given.

However, these symptoms were so vague that the UK emergency departments almost immediately saw an increase in patients worried they were as they were described.

Still, German researchers say such symptoms need to be followed up in vaccine recipients. Blood tests can detect the antibodies.

Doctors in Germany and Norway have treated patients with blood-thinning drugs to stop the clot from growing and with intravenous immunoglobulin, which can help clear up the misdirected antibodies that are causing the problem.

The researchers there and the US federal health authorities advised against the use of a conventional blood thinner, heparin, on Tuesday and recommended that alternative drugs be chosen instead. The reason is that the disorder is very similar to a rare syndrome caused by heparin and it is possible that heparin could make the situation worse in these patients.

Heparin could “do a lot of damage,” said Dr. Marks.

German researchers have stressed that treatment should start as soon as possible as the condition can worsen quickly.

We do not know yet. The six cases studied in people who received the J&J vaccine all involved women. However, this number is so small that no clear conclusions can be drawn from it.

When asked on Tuesday whether the use of contraception could be a risk factor, US health officials said they knew no connection.

In Europe, it initially appeared that women were at a higher risk of blood clots associated with the AstraZeneca vaccine, although in some cases men who had received the vaccine were affected.

Upon closer inspection, it was found that in some countries more women overall received the vaccine because they were overrepresented among health workers. UK regulators now say they have no evidence as to whether men or women are more likely to be affected by blood clots.

The FDA did not find any similar cases in people who received the Moderna or Pfizer-BioNTech vaccines.

However, decreased platelet counts have been reported in a few patients who received the Moderna, Pfizer-BioNTech and AstraZeneca vaccines. One recipient, a doctor in Florida, died of a cerebral haemorrhage when his platelet counts failed to restore, and others were hospitalized. US health officials have stated that the cases are being investigated, but they have not reported the results of those reviews and have yet to advise that they are linked to the vaccines.

Benjamin Mueller contributed to the reporting.

Categories
Business

High Bidder for Tribune Newspapers Is an Influential Liberal Donor

Mr. Wyss, who has pledged to donate half of his money to charity, has donated hundreds of millions to environmental and conservation causes. Through his foundations, he has gradually increased his donations to groups promoting abortion rights, minimum wage increases, and other progressive causes.

He became a member of the Democracy Alliance, a club of liberal donors, and the board of directors of the Center for American Progress, a think tank in Washington that began with the support of the Democracy Alliance donors. The think tank and its sister faction have received more than $ 6.1 million from foundations affiliated with Mr. Wyss, according to tax returns.

Mr. Podesta, the founder of the Center for American Progress, has also advised the Wyss Foundation on, among other things, the hiring of the executive director of the Hub Project, Arkadi Gerney, a former official of the Center for American Progress.

The Hub Project grew out of the idea that Democrats should more effectively convey their arguments through the news media and directly to voters. His business plan, a 21-page document prepared for the Wyss Foundation in 2015, recommended that the group be “funded entirely by the Wyss Foundation to begin with,” and work behind the scenes to “make the public debate and politics dramatic to change positions of key decision makers. The plan added that the Hub project “is not intended to be the public face of campaigns”.

The Hub Project is part of an opaque network managed by Washington-based consulting firm Arabella Advisors that has channeled hundreds of millions of dollars through a number of groups that support Democrats and progressive causes. The system of political funding, which often obscures the identity of donors, is known as dark money, and the Arabella network is a leading vehicle for this on the left.

The Arabella network is similar to the operation created by the Kochs. Democrats have long criticized the Kochs and others who participated in the elusive political issues partly sparked by the 2010 Supreme Court ruling in the Citizens United case.

Arabella’s money goes through four nonprofits that serve as the umbrella structure for a number of groups, including The Hub Project. The nonprofits then pass some of the funds on to other nonprofit groups or super PACs.

Categories
Business

Pfizer CEO says firm can ship 10% extra doses to the U.S. by the tip of Might than beforehand agreed

The bottles for the Pfizer BioNTech COVID-19 vaccine can be prepared prior to the opening of a mass vaccination site in Queens, New York City on February 24, 2021.

Seth Little | Pool | Reuters

Albert Bourla, CEO of Pfizer, said Tuesday that his company had ramped up production of its two-shot coronavirus vaccine and could ship a total of 300 million doses to the U.S. ahead of schedule.

According to Bourla, Pfizer can deliver 10% more cans to the US by the end of May than previously agreed. The company will be able to bring the full 300 million into the US two weeks early, he said.

The announcement came when dozen of states temporarily stopped giving Johnson & Johnson’s single-dose Covid vaccine after the Food and Drug Administration recommended it after six women in the United States developed a rare bleeding disorder in which one woman died and another died in critical condition.

Some states, like New York, said they would use Pfizer’s vaccine instead of the J&J shot for appointments that were already scheduled.

President Joe Biden set a goal last month to get enough Americans vaccinated in time for them to safely gather in small groups for July 4th. He also vowed that every adult in the US would have access to the vaccine by the end of May.

This is the latest news. Please try again.

Categories
Politics

Iran to defy uranium enrichment limits of 2015 nuclear deal after assault

Iran’s chief nuclear negotiator, Abbas Araghchi, attends a nuclear deal review meeting in Tehran.

Raheb Homavandi | Reuters

WASHINGTON – Iran will begin 60% enrichment of uranium, a significant step towards weapons-grade materials, in response to an attack on a key nuclear site, the country’s leading nuclear negotiator told state media on Tuesday.

Iranian Deputy Foreign Minister Abbas Araghchi said he had informed the International Atomic Energy Agency, which oversees the surveillance and inspection of nuclear facilities, of Tehran’s decision. It is estimated that 90% of the enriched uranium is needed to develop a bomb.

The move comes two days after Tehran announced that Natanz’s underground nuclear facility has suffered a power outage. The facility in Natanz was previously affected by cyber attacks.

The Iranian Ali Akbar Salehi, the head of the Iranian Atomic Energy Agency, described the event on Sunday as an act of “nuclear terrorism”. A day later, Iran officially accused Israel of being behind the attack and vowed revenge.

Continue reading: Iran calls Natanz nuclear failure blackout “nuclear terrorism”, while the Israeli media point to a cyber attack

The Natanz blackout coincided with the arrival of Defense Secretary Lloyd Austin in Israel to meet with Prime Minister Benjamin Netanyahu and Defense Secretary Benny Gantz.

The Israeli government did not publicly comment on the incident. The White House said Monday the United States was not involved in the attack.

A view of the Natanz uranium enrichment plant 250 km south of the Iranian capital Tehran.

Raheb Homavandi | Reuters

Iran’s decision to increase uranium enrichment comes because the Biden government is working to revive the 2015 Joint Comprehensive Plan of Action (JCPOA) nuclear deal.

The JCPOA brokered by the Obama administration lifted sanctions against Iran, which had paralyzed its economy and cut its oil exports roughly in half. In exchange for billions of dollars in sanction relief, Iran agreed to dismantle part of its nuclear program and open its facilities to wider international inspections.

In addition to the USA, France, Germany, Great Britain, Russia and China were also signatories to the agreement.

In 2018, then-President Donald Trump kept an election promise and unilaterally withdrew the United States from the JCPOA in what was dubbed the “worst deal ever”. Trump also reintroduced the previously lifted sanctions against Tehran.

After Washington withdrew from the landmark nuclear deal, other signatories to the pact struggled to keep the deal alive.

Categories
Health

Panicked sufferers name medical doctors as Covid vaccine hesitancy rises with J&J blood clot challenge

More Americans are likely to refuse to receive the Covid-19 vaccine from Johnson & Johnson after U.S. health officials said six women developed a rare bleeding disorder with one dead and another in critical condition, experts said for public health and vaccines using CNBC on Tuesday.

The Food and Drug Administration asked states early Tuesday to temporarily stop using J & J’s single-shot vaccine “out of caution” after six women aged 18 to 48 out of the roughly 6.9 million people who received the shot developed blood. A coagulation disorder known as cerebral venous sinus thrombosis, or CVST.

All women developed the condition that occurs when a blood clot forms in the venous sinuses of the brain that prevents blood from flowing back to the heart within about two weeks of receiving the shot from the brain, health officials told reporters on a phone call .

“People who have recently received the vaccine in the past few weeks should be aware if they are looking for symptoms,” said Dr. Anne Schuchat, the deputy chief director of the Centers for Disease Control and Prevention, during a press conference on Tuesday. “If you have received the vaccine and have severe headache, stomach pain, leg pain, or shortness of breath, you should contact your doctor and see a doctor.”

Shortly after the FDA issued the warning, more than a dozen states, as well as some pharmacies, took steps to stop vaccination with J & J’s vaccine. Some replaced scheduled appointments with either the Pfizer or Moderna vaccine. Some doctors say they are already taking calls from worried patients.

People were already skeptical of vaccines before the coronavirus emerged as a new pathogen in China in December 2019, infecting more than 31.2 million Americans and killing at least 562,718 people in just over a year. Warning from U.S. health officials to states is likely to be even more reluctant to take J & J’s shot and the other vaccines, and threatens to hold back the nation’s recovery from the pandemic, health experts told CNBC.

“Unfortunately, this is likely to exacerbate those who are a little hesitant about getting a vaccine,” said Isaac Bogoch, an infectious disease specialist who served on several drug data and safety oversight panels. “Senior public health officials need to continue to be open, honest, transparent, and most importantly, contextualize that this is a low risk.”

According to Dr. Anthony Fauci, President Joe Biden’s chief medical officer, the goal is to vaccinate between 70% and 85% of the US population – or about 232 to 281 million people – to achieve herd immunity and suppress the pandemic.

To date, more than 120 million Americans, or 36% of the total US population, have received at least one dose of a Covid-19 vaccine, according to the CDC. Around 74 million Americans, or 22% of the total US population, are fully vaccinated, according to the CDC. Children under the age of 16 are not yet eligible to shoot in the United States, and some adults are likely to refuse to get a vaccine.

“This puts a wrench in the plans. It will slow down the rollout,” said Dr. Jeffrey Kahn, director of the Berman Institute of Bioethics at Johns Hopkins University. “People will say, ‘I don’t want this, I want one of the others who don’t have this problem,’ even if it’s an extremely rare occurrence.”

Some Americans, especially in black, Hispanic, and rural communities, have already been reluctant to get the J&J vaccine, especially because they found it to be worse than Pfizer and Moderna’s. The highly effective J&J shot, especially against serious illnesses, showed 72% effectiveness in protecting against Covid in the US about a month after inoculation. This is comparable to the effectiveness of Pfizer and Moderna vaccines with two doses of around 95%.

Single-dose vaccines like J & Js were critical to “getting into communities where a two-dose regimen was impractical or even possible,” Kahn said. US health officials used J & J’s vaccine primarily to reach poorer urban and rural areas where residents could not easily get to a vaccination clinic or did not have reliable internet access.

“These communities are also the hardest hit by Covid,” said Kahn. “Interrupting Use of J & J. [is] one stroke to do that effectively and quickly. “

Dr. Stephen Schrantz, who was part of the team leading a J&J vaccine study at the University of Chicago Medicine, said he already had patients who didn’t want the J&J vaccine and said the news would give them more evidence give to say, “See, I told you.”

“I suspect that vaccine adoption and uptake will slow down, there will be a move away from the J&J vaccine even if the CDC and FDA conclude that there is no causal link,” he said. “And as the wearing of masks wears off, there may be more cases like we have in Michigan.”

Dr. Scott Gottlieb, who sits on Pfizer’s board of directors, predicted the move will fuel “the reluctance” of some people to get a Covid vaccine.

“Even if there is no causal link, even if it is extremely rare, we will see that the whole conversation is now ignited on social media,” he told CNBC in an interview.

Dr. Purvi Parikh, an infectious disease allergy and immunology specialist at NYU Langone Health, described the FDA warning Tuesday as a “double-edged sword” and said it would likely raise concerns for already reluctant Americans. She also said she had already received “panic calls” from her own patients about the J&J vaccine.

“But if anything, I would like to repeat again: This only gives me more confidence in our system because these security checks work. Hopefully it will give some people peace of mind,” she added on “Squawk on the Street”. “” “Again, to look at the bigger picture, the benefits still far outweigh the risks of this vaccination.”

Dr. Archana Chatterjee, pediatric infectious disease specialist and member of the FDA’s Advisory Committee on Vaccines and Related Biological Products, echoed Parikh’s remark. She added that there is nothing “unusual” in the way US health officials are addressing the problem.

“This is a normal procedure that occurs,” she said.

“But of course whenever a serious adverse event is reported about a vaccine that raises public concern,” she added. “If you talk about vaccine trust or vaccine reluctance, could it have an impact? It certainly is possible.”

Dr. Paul Offit, another member of the Advisory Committee on Vaccines and Allied Biological Products, hopes Americans will be “rational” about the problem, adding that cases of blood clots seem extremely rare. He noted that convincing people in hard-to-reach communities could be a challenge.

“It should be reassuring to the people that the officials are still looking [at the vaccine], even for rare side effects, “he said.

– CNBC’s Kevin Stankiewicz contributed to this article.

Categories
Business

Tax cheats price the U.S. $1 trillion per yr, I.R.S chief says.

The United States loses approximately $ 1 trillion in unpaid taxes every year, Internal Revenue Service commissioner Charles Rettig estimated Tuesday that the agency lacks the resources to catch tax fraud.

The so-called tax gap has increased over the past decade. The last official estimate by the IRS was that from 2011 to 2013, an average of $ 441 billion a year was under-paid. Most of the unpaid taxes are the result of evasion by the rich and big corporations, Rettig said.

“We are disappointed,” said Rettig during a hearing of the Senate Finance Committee on the upcoming tax season.

Oregon Senator Ron Wyden, the Democratic chairman of the committee, called the $ 1 trillion tax gap a “mind-boggling number.”

“The fact of the matter is that nurses and firefighters have to pay with every paycheck and so many high-flyers can get out,” said Wyden.

Mr. Rettig attributed the growing tax gap to the $ 2 trillion surge in the cryptocurrency sector, which remains lightly regulated and a tax avoidance option. He also pointed to foreign income and corporate abuse of pass-through provisions in the tax code.

The size of the IRS’s enforcement division has declined sharply in recent years, Rettig said, and its ranks have decreased by 17,000 in the past decade.

The spending proposal published by the Biden government last week called for a 10.4 percent increase from the current level of funding for the tax office to $ 13.2 billion. The extra money would be used to better monitor the tax returns of high-income individuals and companies and improve customer service with the IRS